Navigation Links
Lawson researchers engineer a switch to tame aggressive cancers
Date:1/19/2012

LONDON, ON When cancers become aggressive and spread they are the most deadly. Unfortunately, little is known about how to stop this development. A new imaging platform developed by Lawson Health Research Institute's Drs. Ann Chambers and John Lewis is providing insight into just that - the exact moment when cancer cells turn deadly.

Certain proteins, such as E-cadherin, are important for the maintenance of normal tissue structure. When tumors become more aggressive, they often lose E-cadherin, resulting in dramatic changes to their structure, function and ability to spread. But when cancer cells are forced to express E-cadherin, research suggests they behave less aggressively and revert back to normal. Unfortunately, limitations in our ability to directly monitor these effects have made it difficult for scientists to assess the full impact.

In a study released today in PLoS ONE, Drs. Chambers and Lewis reveal a new imaging platform that can modulate and monitor how the effects of a particular protein can affect the entire tumor in real-time. The approach uses a shell-less chick embryo model implanted with human cancer cells. "This accessible set-up allows us to introduce E-cadherin directly into the tumor environment, where it has immediate and dramatic effects," says Dr. Hon Leong, the lead author of this study. "Using 3D time-lapse imaging, the impact of this protein can be visualized and the subsequent effects on cancer cell structure, function and aggressiveness can be monitored in real time for up to 48 hours."

Drs. Chambers and Lewis hope this approach will allow scientists to determine how proteins like E-cadherin can exert their tumor-suppressive properties on the deadly spread of cancer. Through further research, they believe their approach could provide valuable information to help moderate aggressive cancers and improve patient outcomes.

"The insights afforded by this technology will help scientists revisit other proteins thought to be important in metastatic spread, but whose modes of action are not understood, and to watch how they actually function in real-time," says Dr. Chambers.

"Although genomics technology has revealed many new proteins that could force cancers to 'switch' back to their less aggressive state, these new targets have not yet been validated in preclinical models like mice because it is difficult to determine the molecular effects on each individual cancer cell," Dr. Lewis says. "This novel platform allows us to produce compelling photographic evidence of how these anti-cancer proteins work and gain insight into their mechanisms."


'/>"/>
Contact: Sonya Gilpin
sonya.gilpin@lawsonresearch.com
519-685-8500 x75852
Lawson Health Research Institute
Source:Eurekalert

Related medicine news :

1. Lawson proves real people drive research
2. Lawson scientist presents joint pain treatment 2.0
3. UC Davis researchers refine nanoparticles for more accurate delivery of cancer drugs
4. Researchers study how chemicals in drugs and around us impact stem cells
5. University of Granada researchers identify changes in tumor cells that lead to metastasis
6. Cell death researchers identify new Achilles heel in acute myeloid leukemia
7. How immune cells destroy cancer cells - MDC researchers elucidate mechanism
8. UBC researchers identify potential new therapy approach for hepatitis C
9. Mass. General researchers find novel way to prevent drug-induced liver injury
10. Researchers use sugar to halt esophageal cancer in its tracks
11. Little Known About How Autism Affects Teen Drivers: Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, and Omega Station”: a ... is the creation of published author, Chris Jackson. Chris Jackson grew up in ... the Dallas Independent School District teaching English. He is heavily involved in the youth ...
(Date:4/24/2017)... ... ... Life of Purpose Treatment is proud to present “An Evening for Collegiate Recovery ... on May 10th at the University Auditorium. , This benefit concert, featuring Dr. Cheryl ... Collegiate Recovery Community (UFCRC). The concert will kick off the 5th Annual Southeastern CRC ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a ... systems for the treatment of Acute Ischemic Stroke (AIS), today announced it has ... the product advances towards regulatory and clinical phases. , "This is another important ...
(Date:4/23/2017)... ... , ... "An event Horizon is a place where the laws of our ... Music. These are created as Metaphysical Transformations where music, which is the origin of ... ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview her upcoming album ...
(Date:4/22/2017)... ... , ... Ecommerce sales have grown every year since the 1990’s, with 2016 ... consequences of rapid innovation and growth are often neglected in the name of progress. ... and individual’s job to give something back to the planet that provides the resources ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
Breaking Medicine Technology: